Journal article icon

Journal article

Impact of selection bias on the association of kidney function polygenic scores with CKD progression in populations with CKD

Abstract:
Background and hypothesis: The associations of polygenic scores (PGS) for eGFR, with clinical outcomes in prevalent CKD populations have not been well evaluated. Collider bias may distort associations of exposures (including PGS) with outcomes in populations with prevalent disease
Methods: Analyses included European ancestry participants from UK Biobank and three CKD 47 cohorts (SHARP, CRIC and EMPA-KIDNEY) without ESKD at baseline. The exposure was a PGS for 48 low eGFR derived from GWAS of eGFR in the FinnGen cohort. The primary outcomes were eGFR slope (mls/min/1.73m2/year) and kidney disease progression (KDP; defined as first occurrence of incident dialysis, transplantation, sustained eGFR decline by >= 40% or sustained eGFR < 10mls/min/1.73m2 ). Associations between the PGS and eGFR slope were assessed by linear regression and meta-analysed across studies. Associations with KDP were assessed using Cox proportional hazards models.
Results: 107,536 participants in UKB and 6,846 participants from CKD cohorts were included in analyses. In UKB higher PGS was associated with lower baseline eGFR (−5.09 [−5.31; −4.86] ml/min/1.73m2 for those in the top 10% of the PGS versus the rest), with greater risk of KDP (HR 1.36 [1.20 – 1.55]) and faster eGFR decline (-0.12 [-0.14;-0.09] ml/min/1.73m2/year). However, in CKD cohorts, higher PGS was not associated with baseline eGFR (0.15 [−0.73; 1.03] ml/min/1.73m2 ) but was associated with lower risk of KDP (HR 0.76 [0.66 – 0.89]), with a directionally consistent (though non-significant) effect on eGFR decline (+0.19 [-0.01; 0.39] ml/min/1.73m2/year).
Conclusions: A PGS for low eGFR is associated with faster eGFR decline and higher risk of KDP in a population unselected for CKD, but when applied in populations with CKD, non-causal associations are introduced which artificially reverse the associations seen. Applying PGS in populations selected for prevalent disease may lead to qualitatively misleading conclusions on the direction of associations with clinical outcomes.
Publication status:
Accepted
Peer review status:
Peer reviewed

Actions

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Oxford college:
St John's College
Role:
Author
ORCID:
0000-0003-3043-446X
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
ORCID:
0000-0003-4482-4418
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author


More from this funder
Funder identifier:
https://ror.org/02kx7se86
Grant:
TF_001_20220706
TF_001_20220708


Publisher:
Oxford University Press
Journal:
Nephrology Dialysis Transplantation More from this journal
Acceptance date:
2026-09-28
EISSN:
1460-2385
ISSN:
0931-0509


Language:
English
Keywords:
Pubs id:
2462605
Local pid:
pubs:2462605
Deposit date:
2026-09-29
ARK identifier:

Terms of use


Views and Downloads

Views and downloads will return soon






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP